Mitsu Chem Plast Limited announced its audited financial results for the quarter and year ended March 31, 2026, demonstrating strong performance with significant growth in both revenue and profitability. The Board of Directors, which met on May 2, 2026, approved the financial results and recommended a final dividend for shareholders.

For the full year FY26, the company reported revenue from operations of Rs 35,016.95 lakhs, an increase from Rs 33,227.84 lakhs in the previous fiscal year. Total income for FY26 reached Rs 35,084.56 lakhs, compared to Rs 33,287.97 lakhs in FY25. Net profit after tax for the year stood at Rs 1,561.87 lakhs, more than doubling from Rs 725.08 lakhs recorded in FY25. The basic and diluted earnings per share for FY26 improved to Rs 11.50 from Rs 5.39 in the preceding year.

Financial Performance Summary

For the quarter ended March 31, 2026, the company reported revenue from operations of Rs 8,647.46 lakhs and net profit of Rs 771.73 lakhs. The quarterly basic EPS stood at Rs 5.68. The company's total assets as of March 31, 2026, amounted to Rs 21,786.32 lakhs, while total equity and liabilities stood at Rs 21,786.32 lakhs.

Balance Sheet Position

The Board of Directors has recommended a final dividend of 2%, equivalent to Rs 0.20 per equity share on a face value of Rs 10 each for the financial year ended March 31, 2026. This dividend is subject to approval by shareholders at the forthcoming Annual General Meeting. The statutory auditors, M/s. Gokhale & Sathe, Chartered Accountants, have issued an unmodified opinion on the audited financial results for the year ended March 31, 2026.

The company also disclosed that it assessed the impact of the new Labour Codes notified by the Government of India, resulting in an incremental impact of Rs 12.33 lakhs primarily due to changes in wage definition. This amount was presented as a statutory impact under exceptional items in the interim statement for the period ended December 31, 2025. There were no investor complaints pending as of March 31, 2026.

Mitsu chem plast Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission, dated April 14, 2026, pertains to the quarter ended March 31, 2026, and demonstrates the company's adherence to securities market regulations.

Regulatory Compliance Certificate Details

The certificate was issued by Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent. The document confirms compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which governs the maintenance and reporting of shareholding patterns in listed companies.

Share Dematerialization Status

The certificate reveals that Regulation 74(5) is not applicable to Mitsu Chem Plast Limited due to the complete dematerialization of the company's shares. All shareholdings are maintained in electronic form through depositories, eliminating the need for physical share certificates. This digital transformation reflects modern securities market practices and enhances transaction efficiency.

During the quarter ended March 31, 2026, the company received no requests from shareholders for either rematerialization or dematerialization of shares. This indicates stable shareholding patterns and satisfaction with the current electronic holding system among investors.

Corporate Information

Mitsu Chem Plast Limited operates from its registered office at Gala Complex, Mulund (W), Mumbai, with three manufacturing units located in Maharashtra. The company specializes in plastic molding solutions, including blow molding, injection molding, and custom molding services. Managing Director Manish Dedhia signed the compliance certificate, ensuring proper corporate governance and regulatory adherence.

The company's manufacturing facilities are strategically located in MIDC areas of Tarapur, Boisar, and Khalapur, supporting production of industrial containers, furniture parts, automotive components, and medical devices. This diversified product portfolio positions the company across multiple industrial sectors.